Publications

  • Gornalusse, GG, et al., HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells. Nature Biotechnology (2017)
  • Research Features article: Universal donor cells – a revolution against rejection. Issue 102, 2016.
  • Riolobos L, R. K. Hirata, C. J. Turtle, P. R. Wang, G. G. Gornalusse, M. Zavajlevski, S. R. Riddell, and D. W. Russell. 2013. HLA engineering of human pluripotent stem cells. Mol Ther. 21:1232-41.
  • Li LB, Chang KH, Wang PR, Hirata RK, Papayannopoulou T, Russell DW. Trisomy correction in Down syndrome induced pluripotent stem cells. Cell Stem Cell 11, 615-619 (2012).
  • Deyle DR, et al. Normal collagen and bone production by gene-targeted human Osteogenesis Imperfecta iPSCs. Mol Ther 20, 204-213 (2012).
  • Khan, I.F., Hirata, R.K., and Russell, D.W. (2011). AAV-mediated gene targeting methods for human cells. Nature Protocols6, 482-501.
  • Khan, I.F., Hirata, R.K., Wang, P.R., Li, Y., Kho, J., Nelson, A., Huo, Y., Zavaljevski, M., Ware, C., and Russell, D.W. (2010). Engineering of human pluripotent stem cells by AAV-mediated gene targeting. Mol Ther 18, 1192-1199.
  • Miller DG, Wang PR, Petek LM, Hirata RK, Sands MS, Russell DW. Gene targeting in vivo by adeno-associated virus vectors. Nat Biotechnol 24, 1022-1026 (2006).
  • Chamberlain, J.R., Schwarze, U., Wang, P., Hirata, R.K., Hankenson, K.D., Pace, J.M., Underwood, R.A., Song, K.M., Sussman, M., Byers, P.H., et al. (2004). Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 303, 1198-1201.
  • Inoue, N., Hirata, R.K., and Russell, D.W. (1999). High-fidelity correction of mutations at multiple chromosomal positions by adeno-associated virus vectors. J Virol 73, 7376-7380.